| Purity: | 99 |
|---|---|
| Model Number: | 202138-50-9 |
| Brand Name: | NJBN STEROID |
| Grade Standard: | Medicine Grade |
| Type: | Vitamins, Amino Acids and Coenzymes |
| Place of Origin: | China (Mainland) |
| EINECS No.: | 202138-50-9 |
| MF: | C23H34N5O14P |
| Other Names: | Tenofovir disoproxil fumarate |
| CAS No.: | 202138-50-9 |
| Sample: | Free |
| Market: | Worldwide |
Quick Details
Specifications
Tenofovir Disoproxil Fumarate 202138-50-9 Used For Skin Lightening And Anti-melasma
Product Name: Tenofovir disoproxil fumarate
Synonyms: Tenofovir disoproxil fumarate;TENOFOVIR DISOPROXIC;9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine fumarate;2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, bis(2,2-dimethylpropyl) ester, 5-oxide, (R)-;Aids031697;Aids-031697;Bis(neopentyloc)pmpa;Tenofovir diisoproxil fuMarate
CAS: 202138-50-9
MF: C23H34N5O14P
MW: 635.51
Chemical Properties White Solid
Usage tyrosinase inhibitor used for skin lightening and anti-melasma
COA
Medical Applciation
HIV-1 infection: Tenofovir is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 2 years of age and older.[5] This indication is based on analyses of plasma HIV-1 RNA levels and CD4 cell counts in controlled studies of tenofovir in treatment-naive and treatment-experienced adults.
Tenofovir is indicated for the treatment of chronic hepatitis B in adults and pediatric patients 12 years of age and older.
Product Name: Tenofovir disoproxil fumarate
Synonyms: Tenofovir disoproxil fumarate;TENOFOVIR DISOPROXIC;9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine fumarate;2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, bis(2,2-dimethylpropyl) ester, 5-oxide, (R)-;Aids031697;Aids-031697;Bis(neopentyloc)pmpa;Tenofovir diisoproxil fuMarate
CAS: 202138-50-9
MF: C23H34N5O14P
MW: 635.51
Chemical Properties White Solid
Usage tyrosinase inhibitor used for skin lightening and anti-melasma
COA
|
Product name |
Tenofovir Disoproxil Fumarate |
CAS no. |
202138-50-9 |
|
|
Items |
Specifications |
Results |
||
|
Appearance |
A White to off white crystalline powder |
White crystalline powder |
||
|
Solubility |
Freely soluble in DMF and in methanol, |
Conform |
||
|
Identification |
A).By IR: Positive |
Conform |
||
|
B).By HPLC: Positive |
Conform |
|||
|
Residue on ignition |
0.2% max |
complies |
||
|
Water(By K.F) |
1.0% max |
0.4% |
||
|
Heavy metals |
20ppm max |
Conform |
||
|
Related Substance |
a(Tenofovir): 0.15% max |
Not detected |
||
|
b(Adenine): 0.15% max |
Not detected |
|||
|
c(Tenofovir isoproxil monoester): 1.0% max |
0.29% |
|||
|
d(Tenofovir Disoproxil ethyl ester):0.15 max |
Not detected |
|||
|
e(Tenofovir isopropyl isoproxil ): 0.3% max |
Not detected |
|||
|
f(Tenofovir Disoproxil carbamate):0.15% max |
Not detected |
|||
|
g(Tenofovir Disoproxil Dimer):0.15% |
Not detected |
|||
|
Any Individual unspecified impuriy:0.1% |
0.09% |
|||
|
Total impurity: 2.0% max |
0.40% |
|||
|
Enantiomeric Purity |
1.0% max |
Not detected |
||
|
Tenofovir Disoproxil Related compound B |
5PPM max |
Not detected |
||
|
Fumaric Acid |
17.5~19.0% |
18.03% |
||
|
Residual solvents |
Ethanol: 5000ug/g max |
1159ug/g |
||
|
Isopropyl alcohol: 5000ug/g max |
1077ug/g |
|||
|
Methylene chloride: 600ug/g max |
Not detected |
|||
|
NMP: 530ug/g max |
Not detected |
|||
|
Assay (on anhydrous basis) |
98.0% to 102.0% |
99.25% |
||
|
Conclusion |
Comply with USP34 |
|||
Medical Applciation
HIV-1 infection: Tenofovir is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 2 years of age and older.[5] This indication is based on analyses of plasma HIV-1 RNA levels and CD4 cell counts in controlled studies of tenofovir in treatment-naive and treatment-experienced adults.
Tenofovir is indicated for the treatment of chronic hepatitis B in adults and pediatric patients 12 years of age and older.
